Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Dose Titration Study of Quetiapine XR in the Treatment of Postpartum Depression in Nonlactating Women Diagnosed With Bipolar Disorder (BD), Type II.

NCT01527448 is registered in ClinicalTrials.gov with BC Women's Hospital & Health Centre as lead sponsor.

NCT NCT01527448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01527448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Dose Titration Study of Quetiapine XR in the Treatment of Postpartum Depression in Nonlactating Women Diagnosed With Bipolar Disorder (BD), Type II.
Lead sponsor
BC Women's Hospital & Health Centre
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2008
Completion date
July 31, 2010
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum depression